77 related articles for article (PubMed ID: 27260087)
1. The effects of chitosan/miR-200c nanoplexes on different stages of cancers in breast cancer cell lines.
Kaban K; Salva E; Akbuga J
Eur J Pharm Sci; 2016 Dec; 95():103-110. PubMed ID: 27260087
[No Abstract] [Full Text] [Related]
2. In Vitro Dose Studies on Chitosan Nanoplexes for microRNA Delivery in Breast Cancer Cells.
Kaban K; Salva E; Akbuga J
Nucleic Acid Ther; 2017 Feb; 27(1):45-55. PubMed ID: 27763825
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell.
Liu J; Meng T; Yuan M; Wen L; Cheng B; Liu N; Huang X; Hong Y; Yuan H; Hu F
Int J Nanomedicine; 2016; 11():6713-6725. PubMed ID: 28003747
[TBL] [Abstract][Full Text] [Related]
4. Effect of silibinin-loaded nano-niosomal coated with trimethyl chitosan on miRNAs expression in 2D and 3D models of T47D breast cancer cell line.
Yazdi Rouholamini SE; Moghassemi S; Maharat Z; Hakamivala A; Kashanian S; Omidfar K
Artif Cells Nanomed Biotechnol; 2018 May; 46(3):524-535. PubMed ID: 28509572
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol and Morpholine Grafted Cationic Amphiphilic Copolymers for miRNA-34a Delivery.
Sharma S; Mazumdar S; Italiya KS; Date T; Mahato RI; Mittal A; Chitkara D
Mol Pharm; 2018 Jun; 15(6):2391-2402. PubMed ID: 29747513
[TBL] [Abstract][Full Text] [Related]
6. miRNA expression patterns in chemoresistant breast cancer tissues.
Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
[TBL] [Abstract][Full Text] [Related]
7. Physicochemical and biological characterization of chitosan-microRNA nanocomplexes for gene delivery to MCF-7 breast cancer cells.
Santos-Carballal B; Aaldering LJ; Ritzefeld M; Pereira S; Sewald N; Moerschbacher BM; Götte M; Goycoolea FM
Sci Rep; 2015 Sep; 5():13567. PubMed ID: 26324407
[TBL] [Abstract][Full Text] [Related]
8. MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.
Bai WD; Ye XM; Zhang MY; Zhu HY; Xi WJ; Huang X; Zhao J; Gu B; Zheng GX; Yang AG; Jia LT
Int J Cancer; 2014 Sep; 135(6):1356-68. PubMed ID: 24615544
[TBL] [Abstract][Full Text] [Related]
9. Oxaliplatin-chitosan nanoparticles induced intrinsic apoptotic signaling pathway: a "smart" drug delivery system to breast cancer cell therapy.
Vivek R; Thangam R; Nipunbabu V; Ponraj T; Kannan S
Int J Biol Macromol; 2014 Apr; 65():289-97. PubMed ID: 24472507
[TBL] [Abstract][Full Text] [Related]
10. miR-200c enhances radiosensitivity of human breast cancer cells.
Lin J; Liu C; Gao F; Mitchel RE; Zhao L; Yang Y; Lei J; Cai J
J Cell Biochem; 2013 Mar; 114(3):606-15. PubMed ID: 22991189
[TBL] [Abstract][Full Text] [Related]
11. miRNA-200c increases the sensitivity of breast cancer cells to doxorubicin through the suppression of E-cadherin-mediated PTEN/Akt signaling.
Chen Y; Sun Y; Chen L; Xu X; Zhang X; Wang B; Min L; Liu W
Mol Med Rep; 2013 May; 7(5):1579-84. PubMed ID: 23546450
[TBL] [Abstract][Full Text] [Related]
12. Specific targeting delivery to MUC1 overexpressing tumors by albumin-chitosan nanoparticles conjugated to DNA aptamer.
Esfandyari-Manesh M; Mohammadi A; Atyabi F; Nabavi SM; Ebrahimi SM; Shahmoradi E; Varnamkhasti BS; Ghahremani MH; Dinarvand R
Int J Pharm; 2016 Dec; 515(1-2):607-615. PubMed ID: 27989825
[TBL] [Abstract][Full Text] [Related]
13. Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma.
Cosco D; Cilurzo F; Maiuolo J; Federico C; Di Martino MT; Cristiano MC; Tassone P; Fresta M; Paolino D
Sci Rep; 2015 Dec; 5():17579. PubMed ID: 26620594
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
[TBL] [Abstract][Full Text] [Related]
15. Development and Evaluation of Artesunate-Loaded Chitosan-Coated Lipid Nanocapsule as a Potential Drug Delivery System Against Breast Cancer.
Tran TH; Nguyen TD; Poudel BK; Nguyen HT; Kim JO; Yong CS; Nguyen CN
AAPS PharmSciTech; 2015 Dec; 16(6):1307-16. PubMed ID: 25787869
[TBL] [Abstract][Full Text] [Related]
16. pH-responsive drug delivery of chitosan nanoparticles as Tamoxifen carriers for effective anti-tumor activity in breast cancer cells.
Vivek R; Nipun Babu V; Thangam R; Subramanian KS; Kannan S
Colloids Surf B Biointerfaces; 2013 Nov; 111():117-23. PubMed ID: 23787278
[TBL] [Abstract][Full Text] [Related]
17. Dextran-coated iron oxide nanoparticle for delivery of miR-29a to breast cancer cell line.
Yalcin S
Pharm Dev Technol; 2019 Oct; 24(8):1032-1037. PubMed ID: 31159615
[TBL] [Abstract][Full Text] [Related]
18. Enhanced apoptotic and anticancer potential of paclitaxel loaded biodegradable nanoparticles based on chitosan.
Gupta U; Sharma S; Khan I; Gothwal A; Sharma AK; Singh Y; Chourasia MK; Kumar V
Int J Biol Macromol; 2017 May; 98():810-819. PubMed ID: 28189791
[TBL] [Abstract][Full Text] [Related]
19. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
[TBL] [Abstract][Full Text] [Related]
20. MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel.
Zhang HD; Sun DW; Mao L; Zhang J; Jiang LH; Li J; Wu Y; Ji H; Chen W; Wang J; Ma R; Cao HX; Wu JZ; Tang JH
Biochem Biophys Res Commun; 2015 Oct; 465(4):702-13. PubMed ID: 26299922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
